Under the new rules, how will you deal with the prescription and dispensing of drugs and products that are not included in the Common Practice Agreement under Rule 21 NVC36.0809(b)(3)(A)(B) and 21 NVC32M.0109(b)(3)(A)(B)? No common practice agreement can effectively cover any clinical situation. Therefore, the collaborative practice agreement should not and should not replace the exercise of professional judgment by nurse`s Practitioner. There are situations that concern patient care, both frequent and unusual, that require the individual exercise of the clinical judgment of the Practitioner De Nurse. What will be the process of consultation, meetings and meeting documentation? Describe some patients or disease management situations that the primary or assisted physician will only see or see in consultation with you. Meetings are held every six (6) months between the senior physician and the nurse. What medications and devices will you prescribe at each training ground? You can list by certain medications or categories of drugs. A detailed description of the categories of drugs and equipment to treat the most common health problems in your particular practice can be developed. For example: categories of drugs such as anti-Semites, oral hypoglycemic drugs/insulin, oral hormones and contraceptives, cephalosporins, aminoglycoids, antivirals, antiasthmatics, diuretics, antihypertensives, etc. may be indicated. Exceptions may be prescribed according to classes of drugs or certain drugs in a class or routes of administration.

This is not a complete list of questions or statements that should be considered for your collaborative practice agreement, but to guide your development of the collaborative practice agreement for your practice. The COLLABORATIVE PRACTICE AGREEMENT may be more structured than required by the Sole Agent Rules, but must not be less structured or contain less than the rules require. The following questions and statements are intended to help you write your collaborative practice agreement. How will you define the minimum standards of consultation between the Practitioner nurse / senior physician or the caregiver, as outlined in the Quality Assurance Standards for a Collaborative Practice Agreement? How and what will your documentation contain? Are you going to donate medicines and equipment? If so, you must request distribution privileges through the Board of Pharmacy. When you file, indicate how this will be done to comply with the Pharmacy Board of Directors and dose in accordance with 21NCAC 36.1700. It should be documented how the primary or parent physician and nurse should be permanently available for consultation through direct communications or telecommunications. A nurse practitioner could use one combination of the above approach or another to describe in the collaborative practice agreement the prescribing power for the Practitioner Nurse….